Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: An immunohistological study

Mitsuhiro Yasuda, Fumio Takesue, Sadaaki Inutsuka, Masayuki Honda, Tadahiro Nozoe, Daisuke Korenaga

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Purpose: Cyclin B1 is a key regulator of progression through the G2/M transition during the cell cycle. Although cyclin B1 proteins are overexpressed in various types of human cancers, the relationship between cyclin B1 status in gastric cancer and its clinical significance remains unknown. Methods: We examined cyclin B1 expression by immunohistological means in 61 patients with gastric cancer in terms of histological type, tumor invasion, and metastatic behavior. Specimens were considered positive when the cytoplasm of over 10% of the cancer cell population was stained. Results: Cyclin B1 was overexpressed in 32 (53%) of 61 patients with gastric cancer. Tumors that expressed cyclin B1 were predominant in older patients, in well- and moderately differentiated adenocarcinomas and in expanding-growth type tumors. Conversely, expression of cyclin B1 was lower in poorly differentiated adenocarcinomas, and in those of the infiltrative growth type. Moreover, the disease was more advanced (stages III and IV) and widespread nodal involvement was more frequent when cyclin B1 expression was low. Logistic regression analyses showed that histological type is a significant factor related to cyclin B1 protein expression. Conclusions: These findings suggested that cyclin B1 protein overexpression is closely associated with less aggressive tumor behavior. Therefore, G2/M cyclin alternatives and the possible role of cyclins in cancer development warrants further attention.

Original languageEnglish
Pages (from-to)412-416
Number of pages5
JournalJournal of Cancer Research and Clinical Oncology
Volume128
Issue number8
DOIs
Publication statusPublished - Sep 23 2002

Fingerprint

Cyclin B1
Stomach Neoplasms
Neoplasms
Cyclin G2
Adenocarcinoma
Proteins
Cyclins
Growth
Cell Cycle
Cytoplasm
Logistic Models
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance : An immunohistological study. / Yasuda, Mitsuhiro; Takesue, Fumio; Inutsuka, Sadaaki; Honda, Masayuki; Nozoe, Tadahiro; Korenaga, Daisuke.

In: Journal of Cancer Research and Clinical Oncology, Vol. 128, No. 8, 23.09.2002, p. 412-416.

Research output: Contribution to journalArticle

Yasuda, Mitsuhiro ; Takesue, Fumio ; Inutsuka, Sadaaki ; Honda, Masayuki ; Nozoe, Tadahiro ; Korenaga, Daisuke. / Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance : An immunohistological study. In: Journal of Cancer Research and Clinical Oncology. 2002 ; Vol. 128, No. 8. pp. 412-416.
@article{2a9bdd76a42640518db7212b94abd885,
title = "Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance: An immunohistological study",
abstract = "Purpose: Cyclin B1 is a key regulator of progression through the G2/M transition during the cell cycle. Although cyclin B1 proteins are overexpressed in various types of human cancers, the relationship between cyclin B1 status in gastric cancer and its clinical significance remains unknown. Methods: We examined cyclin B1 expression by immunohistological means in 61 patients with gastric cancer in terms of histological type, tumor invasion, and metastatic behavior. Specimens were considered positive when the cytoplasm of over 10{\%} of the cancer cell population was stained. Results: Cyclin B1 was overexpressed in 32 (53{\%}) of 61 patients with gastric cancer. Tumors that expressed cyclin B1 were predominant in older patients, in well- and moderately differentiated adenocarcinomas and in expanding-growth type tumors. Conversely, expression of cyclin B1 was lower in poorly differentiated adenocarcinomas, and in those of the infiltrative growth type. Moreover, the disease was more advanced (stages III and IV) and widespread nodal involvement was more frequent when cyclin B1 expression was low. Logistic regression analyses showed that histological type is a significant factor related to cyclin B1 protein expression. Conclusions: These findings suggested that cyclin B1 protein overexpression is closely associated with less aggressive tumor behavior. Therefore, G2/M cyclin alternatives and the possible role of cyclins in cancer development warrants further attention.",
author = "Mitsuhiro Yasuda and Fumio Takesue and Sadaaki Inutsuka and Masayuki Honda and Tadahiro Nozoe and Daisuke Korenaga",
year = "2002",
month = "9",
day = "23",
doi = "10.1007/s00432-002-0359-9",
language = "English",
volume = "128",
pages = "412--416",
journal = "Journal of Cancer Research and Clinical Oncology",
issn = "0171-5216",
publisher = "Springer Verlag",
number = "8",

}

TY - JOUR

T1 - Overexpression of cyclin B1 in gastric cancer and its clinicopathological significance

T2 - An immunohistological study

AU - Yasuda, Mitsuhiro

AU - Takesue, Fumio

AU - Inutsuka, Sadaaki

AU - Honda, Masayuki

AU - Nozoe, Tadahiro

AU - Korenaga, Daisuke

PY - 2002/9/23

Y1 - 2002/9/23

N2 - Purpose: Cyclin B1 is a key regulator of progression through the G2/M transition during the cell cycle. Although cyclin B1 proteins are overexpressed in various types of human cancers, the relationship between cyclin B1 status in gastric cancer and its clinical significance remains unknown. Methods: We examined cyclin B1 expression by immunohistological means in 61 patients with gastric cancer in terms of histological type, tumor invasion, and metastatic behavior. Specimens were considered positive when the cytoplasm of over 10% of the cancer cell population was stained. Results: Cyclin B1 was overexpressed in 32 (53%) of 61 patients with gastric cancer. Tumors that expressed cyclin B1 were predominant in older patients, in well- and moderately differentiated adenocarcinomas and in expanding-growth type tumors. Conversely, expression of cyclin B1 was lower in poorly differentiated adenocarcinomas, and in those of the infiltrative growth type. Moreover, the disease was more advanced (stages III and IV) and widespread nodal involvement was more frequent when cyclin B1 expression was low. Logistic regression analyses showed that histological type is a significant factor related to cyclin B1 protein expression. Conclusions: These findings suggested that cyclin B1 protein overexpression is closely associated with less aggressive tumor behavior. Therefore, G2/M cyclin alternatives and the possible role of cyclins in cancer development warrants further attention.

AB - Purpose: Cyclin B1 is a key regulator of progression through the G2/M transition during the cell cycle. Although cyclin B1 proteins are overexpressed in various types of human cancers, the relationship between cyclin B1 status in gastric cancer and its clinical significance remains unknown. Methods: We examined cyclin B1 expression by immunohistological means in 61 patients with gastric cancer in terms of histological type, tumor invasion, and metastatic behavior. Specimens were considered positive when the cytoplasm of over 10% of the cancer cell population was stained. Results: Cyclin B1 was overexpressed in 32 (53%) of 61 patients with gastric cancer. Tumors that expressed cyclin B1 were predominant in older patients, in well- and moderately differentiated adenocarcinomas and in expanding-growth type tumors. Conversely, expression of cyclin B1 was lower in poorly differentiated adenocarcinomas, and in those of the infiltrative growth type. Moreover, the disease was more advanced (stages III and IV) and widespread nodal involvement was more frequent when cyclin B1 expression was low. Logistic regression analyses showed that histological type is a significant factor related to cyclin B1 protein expression. Conclusions: These findings suggested that cyclin B1 protein overexpression is closely associated with less aggressive tumor behavior. Therefore, G2/M cyclin alternatives and the possible role of cyclins in cancer development warrants further attention.

UR - http://www.scopus.com/inward/record.url?scp=0036037705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036037705&partnerID=8YFLogxK

U2 - 10.1007/s00432-002-0359-9

DO - 10.1007/s00432-002-0359-9

M3 - Article

C2 - 12200597

AN - SCOPUS:0036037705

VL - 128

SP - 412

EP - 416

JO - Journal of Cancer Research and Clinical Oncology

JF - Journal of Cancer Research and Clinical Oncology

SN - 0171-5216

IS - 8

ER -